Bausch Health Companies Inc. Increase (Decrease) in Accounts Receivable
Bausch Health Companies Inc. (BHC) reported Increase (Decrease) in Accounts Receivable of -$78.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-07-30
- Bausch Health Companies Inc. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $70.00M, a 23.08% decline year-over-year.
- Bausch Health Companies Inc. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$148.00M.
- Bausch Health Companies Inc. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was -$65.00M, a 162.50% decline year-over-year.
- Bausch Health Companies Inc. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $218.00M.
- Bausch Health Companies Inc. increase (decrease) in accounts receivable for fiscal 2025 was $134.00M, a 37.96% decline from fiscal 2024.
- Bausch Health Companies Inc. increase (decrease) in accounts receivable for fiscal 2024 was $216.00M, a 10.77% increase from fiscal 2023.
- Bausch Health Companies Inc. increase (decrease) in accounts receivable for fiscal 2023 was $195.00M, a 242.11% increase from fiscal 2022.
- Bausch Health Companies Inc. increase (decrease) in accounts receivable for fiscal 2022 was $57.00M, a 75.11% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 3 month as first filed | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 6 month as first filed | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 9 month as first filed | Increase (Decrease) in Accounts Receivable 12 month | Increase (Decrease) in Accounts Receivable 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $70.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$78.00M 10-Q · filed 2026-07-30 | -$143.00M derived: sum of 3 quarters · filed 2026-07-30 | $75.00M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2026-03-31 | -$148.00M 10-Q · filed 2026-04-30 | -$213.00M derived: sum of 2 quarters · filed 2026-04-30 | $5.00M derived: sum of 3 quarters · filed 2026-04-30 | $96.00M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-12-31 | -$65.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $153.00M derived: sum of 2 quarters · filed 2026-02-19 | $244.00M derived: sum of 3 quarters · filed 2026-07-30 | $134.00M 10-K · filed 2026-02-19 | ||||
| 2025-09-30 | $218.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $309.00M derived: sum of 2 quarters · filed 2026-07-30 | $199.00M 10-Q · filed 2025-10-30 | $303.00M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-06-30 | $91.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$19.00M 10-Q · filed 2026-07-30 | $85.00M derived: sum of 3 quarters · filed 2026-07-30 | $62.00M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-03-31 | -$110.00M 10-Q · filed 2026-04-30 | -$6.00M derived: sum of 2 quarters · filed 2026-04-30 | -$29.00M derived: sum of 3 quarters · filed 2026-04-30 | $43.00M derived: sum of 4 quarters · filed 2026-04-30 | ||||
| 2024-12-31 | $104.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $81.00M derived: sum of 2 quarters · filed 2026-02-19 | $153.00M derived: sum of 3 quarters · filed 2026-02-19 | $216.00M 10-K · filed 2026-02-19 | ||||
| 2024-09-30 | -$23.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $49.00M derived: sum of 2 quarters · filed 2025-10-30 | $112.00M 10-Q · filed 2025-10-30 | $131.00M derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2024-06-30 | $72.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $135.00M 10-Q · filed 2025-07-31 | $154.00M derived: sum of 3 quarters · filed 2026-02-19 | $385.00M derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2024-03-31 | $63.00M 10-Q · filed 2025-05-01 | $82.00M derived: sum of 2 quarters · filed 2026-02-19 | $313.00M derived: sum of 3 quarters · filed 2026-02-19 | $366.00M derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2023-12-31 | $19.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $250.00M derived: sum of 2 quarters · filed 2026-02-19 | $303.00M derived: sum of 3 quarters · filed 2026-02-19 | $195.00M 10-K · filed 2026-02-19 | ||||
| 2023-09-30 | $231.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $284.00M derived: sum of 2 quarters · filed 2024-10-31 | $176.00M 10-Q · filed 2024-10-31 | $207.00M derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2023-06-30 | $53.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$55.00M 10-Q · filed 2024-08-01 | -$24.00M derived: sum of 3 quarters · filed 2025-02-20 | $109.00M derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2023-03-31 | -$108.00M 10-Q · filed 2024-05-02 | -$77.00M derived: sum of 2 quarters · filed 2025-02-20 | $56.00M derived: sum of 3 quarters · filed 2025-02-20 | $146.00M derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2022-12-31 | $31.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $164.00M derived: sum of 2 quarters · filed 2025-02-20 | $254.00M derived: sum of 3 quarters · filed 2025-02-20 | $57.00M 10-K · filed 2025-02-20 | ||||
| 2022-09-30 | $133.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $223.00M derived: sum of 2 quarters · filed 2023-11-02 | $26.00M 10-Q · filed 2023-11-02 | $78.00M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-06-30 | $90.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$107.00M 10-Q · filed 2023-08-03 | -$55.00M derived: sum of 3 quarters · filed 2024-02-22 | $74.00M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-03-31 | -$197.00M 10-Q · filed 2023-05-04 | -$145.00M derived: sum of 2 quarters · filed 2024-02-22 | -$16.00M derived: sum of 3 quarters · filed 2024-02-22 | $92.00M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2021-12-31 | $52.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $181.00M derived: sum of 2 quarters · filed 2024-02-22 | $289.00M derived: sum of 3 quarters · filed 2024-02-22 | $229.00M 10-K · filed 2024-02-22 | ||||
| 2021-09-30 | $129.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $237.00M derived: sum of 2 quarters · filed 2022-11-03 | $177.00M 10-Q · filed 2022-11-03 | $74.00M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-06-30 | $108.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $48.00M 10-Q · filed 2022-08-09 | -$55.00M derived: sum of 3 quarters · filed 2023-02-23 | $301.00M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-03-31 | -$60.00M 10-Q · filed 2022-05-10 | -$163.00M derived: sum of 2 quarters · filed 2023-02-23 | $193.00M derived: sum of 3 quarters · filed 2023-02-23 | -$161.00M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2020-12-31 | -$103.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $253.00M derived: sum of 2 quarters · filed 2023-02-23 | -$101.00M derived: sum of 3 quarters · filed 2023-02-23 | -$170.00M 10-K · filed 2023-02-23 | ||||
| 2020-09-30 | $356.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $2.00M derived: sum of 2 quarters · filed 2021-11-02 | -$67.00M 10-Q · filed 2021-11-02 | $4.00M derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2020-06-30 | -$354.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | -$423.00M 10-Q · filed 2021-08-03 | -$352.00M derived: sum of 3 quarters · filed 2022-05-11 | -$406.00M derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2020-03-31 | -$69.00M 10-Q · filed 2021-05-04 | $2.00M derived: sum of 2 quarters · filed 2022-05-11 | -$52.00M derived: sum of 3 quarters · filed 2022-05-11 | -$19.00M derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2019-12-31 | $71.00M derived: 8-K 12 month − 10-Q 9 month · filed 2022-05-11 | $17.00M derived: sum of 2 quarters · filed 2022-05-11 | $50.00M derived: sum of 3 quarters · filed 2022-05-11 | -$39.00M 8-K · filed 2022-05-11 | ||||
| 2019-09-30 | -$54.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-03 | -$21.00M derived: sum of 2 quarters · filed 2020-11-03 | -$110.00M 10-Q · filed 2020-11-03 | -$270.00M derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2019-06-30 | $33.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$56.00M 10-Q · filed 2020-08-06 | -$216.00M derived: sum of 3 quarters · filed 2021-05-04 | -$144.00M derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2019-03-31 | -$89.00M 10-Q · filed 2020-05-07 | -$249.00M derived: sum of 2 quarters · filed 2021-05-04 | -$177.00M derived: sum of 3 quarters · filed 2021-05-04 | -$101.00M derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2018-12-31 | -$160.00M derived: 8-K 12 month − 10-Q 9 month · filed 2021-05-04 | -$88.00M derived: sum of 2 quarters · filed 2021-05-04 | -$12.00M derived: sum of 3 quarters · filed 2021-05-04 | -$216.00M 8-K · filed 2021-05-04 | ||||
| 2018-09-30 | $72.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $148.00M derived: sum of 2 quarters · filed 2019-11-04 | -$56.00M 10-Q · filed 2019-11-04 | -$135.00M derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2018-06-30 | $76.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | -$128.00M 10-Q · filed 2019-08-06 | -$207.00M derived: sum of 3 quarters · filed 2020-02-19 | -$93.00M derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2018-03-31 | -$204.00M 10-Q · filed 2019-05-06 | -$283.00M derived: sum of 2 quarters · filed 2020-02-19 | -$169.00M derived: sum of 3 quarters · filed 2020-02-19 | -$189.00M derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2017-12-31 | -$79.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | $35.00M derived: sum of 2 quarters · filed 2020-02-19 | $15.00M derived: sum of 3 quarters · filed 2020-02-19 | -$417.00M 10-K · filed 2020-02-19 | ||||
| 2017-09-30 | $114.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $94.00M derived: sum of 2 quarters · filed 2018-11-06 | -$338.00M 10-Q · filed 2018-11-06 | -$335.00M derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2017-06-30 | -$20.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | -$452.00M 10-Q · filed 2018-08-07 | -$449.00M derived: sum of 3 quarters · filed 2019-02-20 | -$461.00M derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2017-03-31 | -$432.00M 10-Q · filed 2018-05-08 | -$429.00M derived: sum of 2 quarters · filed 2019-02-20 | -$441.00M derived: sum of 3 quarters · filed 2019-02-20 | -$392.00M derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2016-12-31 | $3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | -$9.00M derived: sum of 2 quarters · filed 2019-02-20 | $40.00M derived: sum of 3 quarters · filed 2019-02-20 | $34.00M 10-K · filed 2019-02-20 | ||||
| 2016-09-30 | -$12.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $37.00M derived: sum of 2 quarters · filed 2017-11-07 | $31.00M 10-Q · filed 2017-11-07 | $30.90M 10-Q · filed 2016-11-09 | $1.00M derived: sum of 4 quarters · filed 2018-08-10 | |||
| 2016-06-30 | $49.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $43.00M 10-Q · filed 2017-08-08 | $43.20M 10-Q · filed 2016-08-09 | $13.00M derived: sum of 3 quarters · filed 2018-08-10 | $360.20M derived: sum of 4 quarters · filed 2018-08-10 | |||
| 2016-03-31 | -$6.00M 10-Q · filed 2017-05-09 | -$5.50M 10-Q · filed 2016-06-07 | -$36.00M derived: sum of 2 quarters · filed 2018-08-10 | $311.20M derived: sum of 3 quarters · filed 2018-08-10 | $553.00M derived: sum of 4 quarters · filed 2018-08-10 | |||
| 2015-12-31 | -$30.00M derived: 8-K 12 month − 10-Q 9 month · filed 2018-08-10 | $317.20M derived: sum of 2 quarters · filed 2018-08-10 | $559.00M derived: sum of 3 quarters · filed 2018-08-10 | $626.00M 8-K · filed 2018-08-10 | $625.90M 10-K · filed 2016-04-29 | |||
| 2015-09-30 | $347.20M 10-Q · filed 2015-10-26 | $589.00M derived: sum of 2 quarters · filed 2015-10-26 | $656.00M 10-Q · filed 2016-11-09 | $1.02B derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-06-30 | $241.80M 10-Q · filed 2015-07-28 | $308.80M 10-Q · filed 2016-08-09 | $675.60M derived: sum of 3 quarters · filed 2017-03-01 | $797.00M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-03-31 | $67.00M 10-Q · filed 2016-06-07 | $433.80M derived: sum of 2 quarters · filed 2017-03-01 | $555.20M derived: sum of 3 quarters · filed 2017-03-01 | $608.90M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2014-12-31 | $366.80M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $488.20M derived: sum of 2 quarters · filed 2017-03-01 | $541.90M derived: sum of 3 quarters · filed 2017-03-01 | $572.00M 10-K · filed 2017-03-01 | $572.40M 10-K · filed 2015-02-25 | |||
| 2014-09-30 | $121.40M 10-Q · filed 2015-10-26 | $175.10M derived: sum of 2 quarters · filed 2015-10-26 | $205.20M 10-Q · filed 2015-10-26 | $399.60M derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2014-06-30 | $53.70M 10-Q · filed 2015-07-28 | $83.80M 10-Q · filed 2015-07-28 | $278.20M derived: sum of 3 quarters · filed 2016-04-29 | $223.40M derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2014-03-31 | $30.10M 10-Q · filed 2015-04-30 | $224.50M derived: sum of 2 quarters · filed 2016-04-29 | $169.70M derived: sum of 3 quarters · filed 2016-04-29 | $219.00M derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2013-12-31 | $194.40M derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-29 | $139.60M derived: sum of 2 quarters · filed 2016-04-29 | $188.90M derived: sum of 3 quarters · filed 2016-04-29 | $300.60M 10-K · filed 2016-04-29 | $261.38M 10-K · filed 2014-02-28 | |||
| 2013-09-30 | -$54.80M 10-Q · filed 2014-10-24 | -$52.96M 10-Q · filed 2013-11-01 | -$5.50M derived: sum of 2 quarters · filed 2014-10-24 | $106.20M 10-Q · filed 2014-10-24 | $81.04M 10-Q · filed 2013-11-01 | $92.75M derived: sum of 4 quarters · filed 2015-02-25 | ||
| 2013-06-30 | $49.30M 10-Q · filed 2014-08-01 | $44.77M 10-Q · filed 2013-08-07 | $161.00M 10-Q · filed 2014-08-01 | $134.00M 10-Q · filed 2013-08-07 | $147.55M derived: sum of 3 quarters · filed 2015-02-25 | $330.20M derived: sum of 4 quarters · filed 2015-02-25 | ||
| 2013-03-31 | $111.70M 10-Q · filed 2014-05-09 | $89.23M 10-Q · filed 2013-05-03 | $98.25M derived: sum of 2 quarters · filed 2015-02-25 | $280.90M derived: sum of 3 quarters · filed 2015-02-25 | $272.71M derived: sum of 4 quarters · filed 2015-02-25 | |||
| 2012-12-31 | -$13.45M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $169.20M derived: sum of 2 quarters · filed 2015-02-25 | $161.01M derived: sum of 3 quarters · filed 2015-02-25 | $175.80M 10-K · filed 2015-02-25 | $219.43M 10-K · filed 2013-02-28 | |||
| 2012-09-30 | $182.65M 10-Q · filed 2013-11-01 | $174.46M derived: sum of 2 quarters · filed 2013-11-01 | $189.25M 10-Q · filed 2013-11-01 | $260.00M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-06-30 | -$8.18M 10-Q · filed 2013-08-07 | $6.60M 10-Q · filed 2013-08-07 | $77.35M derived: sum of 3 quarters · filed 2014-02-28 | $120.44M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-03-31 | $14.79M 10-Q · filed 2013-05-03 | $85.53M derived: sum of 2 quarters · filed 2014-02-28 | $128.62M derived: sum of 3 quarters · filed 2014-02-28 | $96.89M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2011-12-31 | $70.75M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $113.84M derived: sum of 2 quarters · filed 2014-02-28 | $82.10M derived: sum of 3 quarters · filed 2014-02-28 | $164.58M 10-K · filed 2014-02-28 | ||||
| 2011-09-30 | $43.09M 10-Q · filed 2012-11-05 | $11.35M derived: sum of 2 quarters · filed 2012-11-05 | $93.83M 10-Q · filed 2012-11-05 | $90.04M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-06-30 | -$31.74M 10-Q · filed 2012-08-03 | -$67.74M 10-Q · filed 2011-08-08 | $50.74M 10-Q · filed 2012-08-03 | $46.96M derived: sum of 3 quarters · filed 2013-02-28 | $28.96M derived: sum of 4 quarters · filed 2013-02-28 | |||
| 2011-03-31 | $82.48M 10-Q · filed 2012-05-04 | $118.48M 10-Q · filed 2011-05-10 | $78.69M derived: sum of 2 quarters · filed 2013-02-28 | $60.70M derived: sum of 3 quarters · filed 2013-02-28 | $72.13M derived: sum of 4 quarters · filed 2013-02-28 | |||
| 2010-12-31 | -$3.79M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | -$21.78M derived: sum of 2 quarters · filed 2013-02-28 | -$10.35M derived: sum of 3 quarters · filed 2013-02-28 | -$25.19M 10-K · filed 2013-02-28 | ||||
| 2010-09-30 | -$18.00M 10-Q · filed 2011-11-04 | -$17.97M 10-Q · filed 2010-11-05 | -$6.56M derived: sum of 2 quarters · filed 2011-11-04 | -$21.40M 10-Q · filed 2011-11-04 | -$21.63M 10-Q · filed 2010-11-05 | -$3.70M derived: sum of 4 quarters · filed 2012-02-29 | ||
| 2010-06-30 | $11.43M 10-Q · filed 2011-08-08 | $11.40M 10-Q · filed 2010-08-06 | -$3.40M 10-Q · filed 2011-08-08 | -$3.66M 10-Q · filed 2010-08-06 | $14.29M derived: sum of 3 quarters · filed 2012-02-29 | $16.23M derived: sum of 4 quarters · filed 2012-02-29 | ||
| 2010-03-31 | -$14.84M 10-Q · filed 2011-05-10 | $2.86M derived: sum of 2 quarters · filed 2012-02-29 | $4.80M derived: sum of 3 quarters · filed 2012-02-29 | $19.00M derived: sum of 4 quarters · filed 2012-02-29 | ||||
| 2009-12-31 | $17.70M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29 | $19.63M derived: sum of 2 quarters · filed 2012-02-29 | $33.84M derived: sum of 3 quarters · filed 2012-02-29 | $27.00M 10-K · filed 2012-02-29 | ||||
| 2009-09-30 | $1.94M 10-Q · filed 2010-11-05 | $16.14M derived: sum of 2 quarters · filed 2010-11-05 | $9.30M 10-Q · filed 2010-11-05 | |||||
| 2009-06-30 | $14.20M 10-Q · filed 2010-08-06 | $7.37M 10-Q · filed 2010-08-06 | ||||||
| 2008-12-31 | -$26.65M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |